Startups
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune disease. Our pipeline targets SIK3 to deliver transformative therapies where unmet need remains high.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 28, 2026 | Coultreon Biopharma Raises $125M in Series A Funding |
Reviews 0
FAQ about Coultreon Biopharma
What has the press written about Coultreon Biopharma?
Parsers VC has collected 2 articles mentioning Coultreon Biopharma, among them “Coultreon Biopharma Raises $125M in Series A Funding” (Apr 28, 2026).
Is Coultreon Biopharma still active?
Coultreon Biopharma is probably closed: its latest activity on Parsers VC dates from Jul 10, 2026.